<code id='FFB8C5C36F'></code><style id='FFB8C5C36F'></style>
    • <acronym id='FFB8C5C36F'></acronym>
      <center id='FFB8C5C36F'><center id='FFB8C5C36F'><tfoot id='FFB8C5C36F'></tfoot></center><abbr id='FFB8C5C36F'><dir id='FFB8C5C36F'><tfoot id='FFB8C5C36F'></tfoot><noframes id='FFB8C5C36F'>

    • <optgroup id='FFB8C5C36F'><strike id='FFB8C5C36F'><sup id='FFB8C5C36F'></sup></strike><code id='FFB8C5C36F'></code></optgroup>
        1. <b id='FFB8C5C36F'><label id='FFB8C5C36F'><select id='FFB8C5C36F'><dt id='FFB8C5C36F'><span id='FFB8C5C36F'></span></dt></select></label></b><u id='FFB8C5C36F'></u>
          <i id='FFB8C5C36F'><strike id='FFB8C5C36F'><tt id='FFB8C5C36F'><pre id='FFB8C5C36F'></pre></tt></strike></i>

          focus

          focus

          author:entertainment    Page View:2
          the U.S. Medicare Handbook is photographed in Washington.
          Pablo Martinez Monsivais/AP

          Roughly 33.4 million adults older than 65 and people with disabilities were enrolled in a Medicare Advantage plan as the calendar flipped to 2024 — another year of steady, albeit slower, growth for the taxpayer-funded program.

          Enrollment increased 7.1% year over year, which would make this year’s annual growth rate identical to last year’s, according to new federal Medicare Advantage enrollment data analyzed by STAT.

          advertisement

          The data reinforce how America’s Medicare program continues to shift toward a more privatized version that has not saved any money for taxpayers, has been linked to inappropriate coding practices, and has restricted care for older and vulnerable patients. And even though the federal government made several changes to Medicare Advantage for 2024 — changes that were vehemently opposed by the health insurance industry — the program’s growth has not been stunted, nor did insurers dramatically slash their offerings.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          Bernie Sanders gets little from pharma CEOs on drug prices
          Bernie Sanders gets little from pharma CEOs on drug prices

          Sen.BernieSanders(I-Vt.)raiseshishandataThursdayhearingonCapitolHillinWashingtontoexaminethecostofpr

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

          DarronCummings/APEliLillysaidFridaythatitwillacquireDermira,asmallbiotechdevelopingdrugsforchronicsk